This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new study from an industry advocacy group in California examines the content of dozens of unregulated intoxicating “hemp” products that are easily available in the Golden State despite being banned by state law. The study, entitled The Great Hemp Hoax , was released Feb. Hemp not really hemp Speaking in a Feb.
The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC. 3% Total THC.
On May 4, 2023, during its annual SupplyChain Conference, the Drug Enforcement Administration (DEA) announced that it is “in the process of modifying [its regulations]” on cannabis constituents based on recommendations from the U.S. Department of Health and Human Services (HHS).
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD. Wier tossed a hemp farm’s $9-million contract dispute suit against an Ore. Due to the immaturity of manufacturing and supplychain logistics, the industry couldn’t ship the hemp to its consumers fast enough. is wrong venue.
17, 2022 – PRESS RELEASE – Raising the standard for cannabis and hemp testing, ACS Laboratory , the largest hemp and cannabis testing facility in the eastern U.S., is pleased to announce the National Hemp Testing Panel – the most comprehensive national hemp testing panel in the industry. BOCA RATON, Fla.,
It is an apt reference to the hemp industry’s current predicament. The Rule has been both eagerly and anxiously anticipated by anyone who interacts with the hemp industry. I decided to take a more philosophical approach in this article and ask whether the Rule will initiate a crisis or create novel opportunities in the hemp industry.
Delta-8 THC, aka delta-8, the intoxicating cannabinoid synthesized from hemp, is making waves across the United States, and especially in states where marijuana remains illegal. That’s because delta-8 is derived from federally legal hemp, which by law contains less than 0.3% delta-9 THC. I tried delta-8 THC: Here’s what it feels like.
Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. cannabinoid hemp and hemp extract.”
As a former foot soldier for the DEA in my country’s failed War on Drugs, I took notice when Bob sued the DEA and brought hemp front and center onto the world stage. I have watched HLG turn its CBD and hemp clients into profitable businesses and watched the next generation of tax revenues on a scale seen never before.
Food and Drug Administration (DEA), contains the active ingredient cannabidiol (CBD) but it does not contain psychoactive molecule THC, which generates the marijuana high. “We supplychain, once rescheduling is complete.”. Epidiolex , the first cannabis pharmaceutical to be approved by the U.S. Pfizer, GW Pharma, Merck & Co.,
Investments in the cannabis industry are now available as ETFs (Exchange Traded Funds) , and marijuana startups are proliferating at every step along the supplychain. want to employ a research scientist to investigate potential products or services, or delivery systems, involving any form of cannabis (except agricultural hemp).
Implementation of supplychain optimization is well underway, with the Company having realized $38 million , including $32 million in Q1 2022, of the $150 million to $200 million in cost savings expected by the end of the first half of FY 2023. $110.4. hemp (including CBD) products and the scope of any regulations by the U.S.
Improved supplychain execution and quality enhancements are leading to commercial success. ” “We made tremendous progress improving our supplychain and right-sizing our manufacturing footprint, bringing supply and demand into balance,” added Mike Lee , CFO. hemp industry in the U.S.,
Investments in the cannabis industry are now available as ETFs (Exchange Traded Funds) , and marijuana startups are proliferating at every step along the supplychain. want to employ a research scientist to investigate potential products or services, or delivery systems, involving any form of cannabis (except agricultural hemp).
THC and hemp when referring to cannabis at, or below, 0.3% As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. And even within that narrow scope, access is tightly limited: only eight DEA-registered bulk manufacturers are allowed to participate. hemp operators.
The benefits of vertical integration are derived through being able to manage all aspects of the supplychain, affording ultimate control over internal costs of production. There are also associated tax advantages (for now), as one division can pass through costs throughout the chain.”
Due to its high English speaking population, its significant diaspora in the United States, and its strong pharmaceutical industry that is already tied to the United States, the Philippines is an attractive cannabis participant, both as part of the supplychain and as a potential sales market. FDA and DEA.
Essay: “The Nature of Hemp and Law: Hazy Regulation”. Essay Summary: Jack outlines the Hemp Farming Act, passed in December of 2018, and the implications of the bill for hemp companies and farmers. Previously a Schedule I substance, hemp was reclassified; hemp has extremely low levels of THC (less than 0.3%).
On October 27, the New York Department of Health (the “ DOH ”) released much anticipated proposed rules to regulate the processing, manufacturing, sale and marketing of cannabinoid hemp products in the state (the “ Rules ”). The Rules contain key terms and definitions that are rarely found in hemp state regulations. Nomenclature.
Companies continue to seek strategic acquisitions, partnerships, and investments as they enter new international markets or seek to relocate a portion of their business or supplychain from higher-risk markets, such as China, to lower-risk markets in Southeast Asia and Africa, or even reshoring back to the U.S. Distressed U.S.
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content